Pharmacoeconomic analysis
- Rationale for increasing funding allocations for health interventions
- Evaluation and adjustment of the standards of care
- Incorporating new medical technologies in the standards of care, treatment protocols and drug lists
- Rationale for shifting budget priorities toward particular drug products and medical devices
- Assessment of alternative medical technologies
Resources available for conducting pharmacoeconomic analysis:
- on-staff HTA experts
- software developers (creation of electronic calculator models, including on-line models)
- collaboration with leading medical research institutions, such as Health Technology Assessment Laboratory (the Russian Presidential Academy of National Economy and Public Administration), Laboratory of Pharmacoeconomics (M.Sechenov Moscow Medical University),Center of Pharmacoeconomics Research
CJSC Aston Consulting, 1999-2021